Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

October 01, 1988; Volume 247,Issue 1

Article

  • You have access
    ERRATUM
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 397;
  • You have access
    Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307).
    P C Wong, A T Chiu, W A Price, M J Thoolen, D J Carini, A L Johnson, R I Taber and P B Timmermans
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 1-7;
  • You have access
    Characterization and function of bradykinin receptors in vascular endothelial cells.
    C P Sung, A J Arleth, K Shikano and B A Berkowitz
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 8-13;
  • You have access
    Involvement of peripheral-type benzodiazepine receptors in the proconvulsant actions of pyrethroid insecticides.
    L L Devaud and T F Murray
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 14-22;
  • You have access
    Identification of a high-affinity peripheral-type benzodiazepine binding site in rat aortic smooth muscle membranes.
    J F French and M A Matlib
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 23-28;
  • You have access
    Sigma receptors in post-mortem human brains.
    A D Weissman, T P Su, J C Hedreen and E D London
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 29-33;
  • You have access
    Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
    P J Silver, R E Lepore, B O'Connor, B M Lemp, L T Hamel, R G Bentley and A L Harris
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 34-42;
  • You have access
    Thromboxane synthesis and actions in isolated adrenergic nerve (pheochromocytoma-12) cells.
    G J Trachte, P J Hook, J R Kemp, E P Acosta and R J Ziegler
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 43-46;
  • You have access
    Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans.
    W K Bickel, M L Stitzer, G E Bigelow, I A Liebson, D R Jasinski and R E Johnson
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 47-53;
  • You have access
    Leukotriene D4-induced homologous desensitization in basal and differentiated U-937 cells: characterization with the partial agonist leukotriene E4 and assessment of receptor reserve.
    J D Winkler, H M Sarau, J J Foley and S T Crooke
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 54-62;
  • You have access
    Identification of 6-keto-prostaglandin E1 obtained from isolated perfused kidney of the rabbit.
    J P Pieroni, F Dray, C R Pace-Asciak and J C McGiff
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 63-68;
  • You have access
    Cardiovascular effects of rat calcitonin gene-related peptide in the conscious rat.
    A L Sirén and G Feuerstein
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 69-78;
  • You have access
    Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
    D M Stone, M Johnson, G R Hanson and J W Gibb
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 79-87;
  • You have access
    Effects of amiloride and 5-(N,N-hexamethylene)amiloride on dopaminergic and cholinergic neurotransmission.
    J K Zubieta, E J Cragoe and L X Cubeddu
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 88-95;
  • You have access
    Effects of salicylate vs. aspirin on renal prostaglandins and function in normal and sodium-depleted dogs.
    E J Zambraski, D C Atkinson and J Diamond
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 96-103;
  • You have access
    Contribution of M2 alpha and M2 beta muscarinic receptors to the action of cholinergic stimuli on prostaglandin synthesis and mechanical function in the isolated rabbit heart.
    N Jaiswal, G Lambrecht, E Mutschler and K U Malik
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 104-113;
  • You have access
    Histamine-induced intracellular free Ca++, inositol phosphates and electrical changes in murine N1E-115 neuroblastoma cells.
    S G Oakes, P A Iaizzo, E Richelson and G Powis
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 114-121;
  • You have access
    Evidence for heterogeneity between pre- and postjunctional alpha-2 adrenoceptors using 9-substituted 3-benzazepines.
    R N Daly, A C Sulpizio, B Levitt, R M DeMarinis, J W Regan, R R Ruffolo and J P Hieble
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 122-128;
  • You have access
    Characterization of hydrolysis of [leu]enkephalin and D-ala2-[L-leu]enkephalin in rat plasma.
    S B Weinberger and J L Martinez
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 129-135;
  • You have access
    Antagonists and agonists interactions with the muscarinic receptor of the rat large airways.
    T Scott and K K McMahon
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 136-142;
  • You have access
    Effects of putative thromboxane receptor agonists and antagonists on rat small intestinal ion transport.
    P L Smith, G P McCafferty, J D Fondacaro, M A Wasserman, E Elton and F M Ryan
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 143-149;
  • You have access
    Carbachol depolarizes and accelerates pacemaker activity in the sinoatrial node of chicks treated with pertussis toxin.
    U Agnarsson, T Tajima and A J Pappano
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 150-155;
  • You have access
    Selective vulnerability of glutathione metabolism and cellular defense mechanisms in rat striatum to manganese.
    J J Liccione and M D Maines
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 156-161;
  • You have access
    Comparison of chronic morphine and placebo infusion in late gestation fetal lambs: effect upon survival and breathing movements.
    G D Olsen, T M Cline and K M Sommer
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 162-168;
  • You have access
    Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    E Sanders-Bush and M Breeding
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 169-173;
  • You have access
    A low dose of xylamine produces sustained and selective decreases in rat brain norepinephrine without evidence of neuronal degeneration.
    M W Dudley, B W Siegel, A M Ogden and D R McCarty
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 174-179;
  • You have access
    Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    P K Sonsalla, L Manzino and R E Heikkila
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 180-185;
  • You have access
    Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats.
    E H Ohlstein, L I Kruse, M Ezekiel and R N Willette
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 186-195;
  • You have access
    Phorbol ester-induced modulation of agonist binding to alpha-1 adrenergic receptors in bovine aortic membranes.
    G Jagadeesh and R C Deth
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 196-202;
  • You have access
    Renal transport kinetics of chlorothiazide in the isolated perfused rat kidney.
    L J Lee, J A Cook and D E Smith
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 203-208;
  • You have access
    Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
    B J Undem, P T Peachell and L M Lichtenstein
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 209-217;
  • You have access
    Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells.
    J A Warner, L M Lichtenstein and D W MacGlashan
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 218-222;
  • You have access
    Functional importance of alpha adrenoceptor-mediated, D600-insensitive Ca++ entry in rabbit aorta.
    R K Hester
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 223-234;
  • You have access
    H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.
    K Inui, T Okano, H Maegawa, M Kato, M Takano and R Hori
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 235-241;
  • You have access
    Use of quinidine inhibition to define the role of the sparteine/debrisoquine cytochrome P450 in metoprolol oxidation by human liver microsomes.
    S V Otton, H K Crewe, M S Lennard, G T Tucker and H F Woods
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 242-247;
  • You have access
    Effects of dichlorobenzamil on calcium currents in clonal GH3 pituitary cells.
    G Suarez-Kurtz and G J Kaczorowski
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 248-253;
  • You have access
    PAF-acether and endotoxin display similar effects on rat mesenteric microvessels: inhibition by specific antagonists.
    V Lagente, Z B Fortes, J Garcia-Leme and B B Vargaftig
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 254-261;
  • You have access
    Interactions between phorbol esters and agents which increase cytosolic calcium in the guinea pig parenchymal strip: direct and indirect effects on the contractile response.
    A W Obianime, S J Hirst and M M Dale
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 262-270;
  • You have access
    Effects of diphenhydramine in the fetal lamb after maternal or fetal administration.
    D W Rurak, S D Yoo, E Kwan, S M Taylor, K W Riggs and J E Axelson
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 271-278;
  • You have access
    Effects of gestational age on the disposition of propranolol in pregnant sheep.
    M A Czuba, G W Mihaly, M S Ching, D J Morgan, K J Hardy and R A Smallwood
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 279-282;
  • You have access
    LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
    A Mülsch, R Busse, S Liebau and U Förstermann
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 283-288;
  • You have access
    Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease.
    I B Lindén, E Nissinen, E Etemadzadeh, S Kaakkola, P Männistö and P Pohto
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 289-293;
  • You have access
    Inversion of the alpha-2 and alpha-1 noradrenergic control of the cortical release of acetylcholine and gamma-aminobutyric acid in morphine-tolerant guinea pigs.
    L Beani, C Bianchi, S Tanganelli, T Antonelli, M Simonato and S Rando
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 294-301;
  • You have access
    Norepinephrine and adenosine triphosphate release in different ratio from guinea pig vas deferens by high potassium chloride, ouabain and monensin.
    T Katsuragi, T Tokunaga, K Miyamoto, L Kuratomi and T Furukawa
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 302-308;
  • You have access
    Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem.
    T Dennis, A Dubois, J Benavides and B Scatton
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 309-322;
  • You have access
    Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.
    S M de Morais and P G Wells
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 323-331;
  • You have access
    Intracerebroventricular morphine decreases descending inhibitions acting on lumbar dorsal horn neuronal activities related to pain in the rat.
    D Bouhassira, L Villanueva and D Le Bars
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 332-342;
  • You have access
    [3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.
    K J Nicklaus, P McGonigle and P B Molinoff
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 343-348;
  • You have access
    Gentamicin-induced increases in cytosolic calcium in pig kidney cells (LLC-PK1).
    P D Holohan, P P Sokol, C R Ross, R Coulson, M E Trimble, D A Laska and P D Williams
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 349-354;
  • You have access
    Effects of N-n-propylnorapomorphine enantiomers on single unit activity of substantia nigra pars compacta and ventral tegmental area dopamine neurons.
    R F Cox, J L Neumeyer and B L Waszczak
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 355-362;
  • You have access
    Beneficial effects of a 5-lipoxygenase inhibitor in endotoxic shock in the rat.
    G Matera, J A Cook, R A Hennigar, G E Tempel, W C Wise, T D Oglesby and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 363-371;
  • You have access
    Cholinergic influences on sleep-wake patterns and breathing movements in the fetus.
    D J Hinman and H H Szeto
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 372-378;
  • You have access
    Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol.
    G A Ordway, C Gambarana and A Frazer
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 379-389;
  • You have access
    Characteristics of somatostatin desensitization in the pituitary tumor cell line AtT-20.
    N Mahy, M Woolkalis, D Manning and T Reisine
    Journal of Pharmacology and Experimental Therapeutics October 1988, 247 (1) 390-396;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 247, Issue 1
1 Oct 1988
  • Table of Contents
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Article
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics